Please use this identifier to cite or link to this item: https://doi.org/10.21256/zhaw-19175
Title: Real-world drug regimes for multiple myeloma in a Swiss population (2012 to 2017) : cost-outcome description
Authors : Eichler, Klaus
Rapold, Ronald
Wieser, Simon
Reich, Oliver
Blozik, Eva
et. al : No
Extent : 1-37
Publisher / Ed. Institution : ZHAW Zürcher Hochschule für Angewandte Wissenschaften
Publisher / Ed. Institution: Winterthur
Issue Date: Oct-2019
License (according to publishing contract) : CC BY 4.0: Attribution 4.0 International
Language : English
Subjects : Multiple myeloma; Drug treatment; Treatment patterns; Costs
Subject (DDC) : 362: Health and social services
615: Pharmacology and therapeutics
Departement: School of Management and Law
Organisational Unit: Winterthur Institute of Health Economics (WIG)
Publication type: Working paper – expertise – study
DOI : 10.21256/zhaw-19175
URI: https://digitalcollection.zhaw.ch/handle/11475/19175
Appears in Collections:Gesundheitsökonomie

Files in This Item:
File Description SizeFormat 
Multiple Myeloma Drug Regimes_2019.pdf527.94 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.